Long synonymous with struggling dairy farmers and perpetual milk glut, Australia’s dairy market is rapidly tightening as the producers compete more aggressively for supply that has been eroded because of drought.
Read More
The flagging housing market and sagging consumer sentiment ahead of the federal and NSW elections have affected the performance of an unlikely ASX-listed exponent – the assisted reproduction outfit Virtus Health (VRT, $3.98).
Read More
Amid the rush by the ASX listed ‘pot stocks’ to grow medical cannabis, the market has overlooked a key question: where will all the therapeutic hooch be processed?
Read More
Recent market entrant Jayride has ambitions to become the ‘bookings.com’ of airport transit services. Elsewhere in the travel sector, the expansive Sealink is navigating choppy waters as it awaits the outcome of a contract to run Sydney’s ferries.
Read More
Two ASX-listed satellite plays are striving to reach for the stars, but to succeed they need to convince investors that a previous high-profile failure in the sector was an aberration
Read More
Not everything’s going right for the smaller banks, but the findings of the Hayne Royal Commission present a perfect opportunity to woo discontented Big Four customers. Should investors follow?
Read More
As with online dating, seeking a suitable partner can be a vexed pursuit for emerging Australian tech plays. As the experience of these two ‘true blue’ stocks attest, the partnering process involves many twists and turns.
Read More
For a sector that has heaped heartbreak on investors over the years, ASX-listed seafood exposures now present an ocean of choice to investors. Most of the expanding school of piscatorial plays are export-oriented – or aspire to be – and leverage Australia’s image of having pristine waters.
Read More
With so many investment babies being thrown out with the murky bathwater, do opportunities abound for the fearless, especially given the market’s positive start to the year?
Read More
2018 began with bundles of promise for small-cap investors, but ended in misery interspersed with some rare delights. Your columnist trawls through his coverage for the highlight and lowlights and highlights potential opportunities for 2019.
Read More
Tin might be one of the world’s most strategic metals, but it’s not reflected in the price of the commodity. But with supply issues looming, this could well change in 2019.
Read More
After some earlier positive trial results, the biotech sector is seeking treatment after some less than impressive results. But does value remain for investors?
Read More
Two recent junior telco listings have been shunned by investors but they highlight the opportunities in the post-NBN world.
Read More
From ‘fake ads’ to top-secret governments to SMEs, ASX-listed cyber security providers are tackling the problems in very different ways.
Read More
We got listed pot stocks and even a listed medicinal opium producer, so it was only a matter of time that a kava play would launch an IPO ahead of an ASX listing.
Read More
While resources pundits regard copper as the commodity most reflective of the world’s economic strength or otherwise, the more obscure zircon arguably is an even better guide.
Read More
With Foster’s Group and Lion taken over by foreign owners some time ago, local investors have been denied an ASX exposure to a major brewer. But for those hankering for a taste for beer there are smaller boutique alternatives
Read More
Given the current swooning stock market there’s plenty of talk about defensive stocks, but in the case of some of our listed defence suppliers that concept has a more literal hue.
Read More
If there’s one thing holding back the electrical vehicle sector it’s ‘range anxiety’ – the sickly feeling that you’re not going to make it to the next sparsely-located charging station and will spend the night by a lonely verge. Here’s a solution.
Read More
In the contact sports sphere, concussion is fast evolving from an acceptable workplace risk to a multi-billion dollar headache for sports organisations and – more pertinently – their insurers.
Read More
For Old King Coal, it’s a case of Coke is It: demand for metallurgical (coking) coal remains robust amid questions about the long-term outlook for thermal coal.
Read More
The listed builders of detached dwellings are holding their own amid a stiffening housing downturn, with the ‘strength in adversity’ message emanating from their recent profit results.
Read More
The dry conditions in many of the key farming regions highlight the importance of water security for our listed agricultural plays. When it comes to water rights, some are in a better position than others.
Read More
If there’s a clear winner from the murky swamp of revelations uncovered by the banking royal commission, it’s the provider of independent administration and investment platforms for the financial advisory industry.
Read More
The listed childcare sector has been popular with investors, but emerging oversupply and affordability issues mean that all is not well in the sandpit. The operators are banking on the government’s revised subsidy scheme to revive their fortunes.
Read More
Fintech Novatti is targeting migrants and foreign students in its quest to become Australia’s next bank. Meanwhile, Raiz (the former Acorns) is shrugging off a poor market reaction to its recent listing as it tries to reform the savings habits of Millennials.
Read MoreFor the recruitment sector it’s been a case of hard labour for the last few years, but there are signs of a reprieve.
Read MoreWe wouldn’t say it’s gone to pot, but the ASX-listed cannabis sector is facing a much-needed reality check as investors realise that the medical marijuana aspirants need more than a ‘grow it and they will come’ strategy.
Read MoreThe rising greenback means bullion continues to be under pressure, but in $A terms it’s a different story and the good times continue to roll for our ASX-listed miners. But with the majors looking fully priced, it’s time to dig a little deeper
Read MoreGrowth stocks have outperformed value stocks in recent times, but the 31 year old value investor Templeton Growth Fund is a patient investor. Elsewhere in the listed investment company sector, a new fund is taking a different approach to ensure it doesn’t trade at a discount to asset backing.
Read MoreBoth Avita Medical and Polynovo are in the game of developing innovative burns and wounds treatments, but investors ascribe disparate valuations. Is the cavernous valuation gap justified?
Read MoreDrug distributor Sigma’s loss of a major contract to supply the burgeoning Chemist Warehouse chain is a bitter pill to swallow, although the company maintains there are positives as well. In the meantime, the whole sector is looking more challenging as new entrants such as Amazon and DHL eye the market.
Read MoreWhile Smart Parking struggles to stay on the entry ramp in the UK following the sacking of its regional CEO and CFO, locally the age-old Hills conglomerate is alive to the sound of parking technology such as number-plate recognition.
Read MorePaying staff accurately and managing travel bookings efficiently might seem like HR 101 but many employers still can’t get it right. But two cloud-based recent ASX entrants are seeking to make the task easier.
Read MoreWith the mortgage broking sector already under the regulatory blowtorch, Mortgage Choice has added to the pain with revelations of unhappy franchisees. But is there value emerging in the marked down shares, as well as those of listed counterpart Australian Financial Group?
Read MoreCarbon components specialist Quickstep is flying high with an ongoing parts contract for the Joint Strike Fighter program, but investors remain wary because the company is yet to turn a profit. Also in the tech space, Sensera has gone to market with a better tool to track mining equipment – and cows.
Read MoreIn the old days, the listing of a broking firm was a sure sign the market had peaked. But has the sector matured? Meanwhile, a niche broker is relying on the wisdom of the masses to seek the best investments.
Read MoreA low key listed life insurer is in an intriguing position following a recent acquisition. Meanwhile, a newly-listed data centre operator has the big players in its sights.
Read MoreThis week The New Criterion drills down into the listed dental sector, which has just expanded by one-third with the listing of a new practice consolidator.
Read MoreThe paradox of the current uranium market is that the more the major producers curtail output because of a stubbornly low price for the commodity, the higher the hopes of a recovery.
Read More